Diurnal variations of urinary enzyme excretion

Clinica Chimica Acta; International Journal of Clinical Chemistry
D MaruhnK D Bock

Abstract

Variations in the urinary excretion of arylsulphatase A, beta-galactosidase, alpha-glucosidase and beta-glucuronidase throughout a 24-h period were studied in 8 healthy subjects. Urine was collected at 3-h intervals and enzyme activities were assayed after gelfiltration of the urine specimens. Significant intra-individual changes of the excretion of all 4 enzymes during the 24-h period were found. Enzyme output was high between 3 a.m. and 9 a.m. and low during the afternoon and evening hours. The most striking pattern was seen for arylsulphatase A. Diurnal variations of urinary enzyme excretion seemed not to be flow dependent. Both modes of expression of enzyme output (mU/min or U/g creatinine) gave corresponding results. It is concluded that for the measurement of the excretion of these enzymes urine should be collected during a fixed time interval, e.g. from 6 a.m. to 9 a.m.

References

Jan 1, 1991·Cancer Chemotherapy and Pharmacology·R SkinnerA W Craft
Jan 1, 1990·Journal of Cancer Research and Clinical Oncology·U Metz-KurschelE Aulbert
Sep 1, 2006·Indian Journal of Clinical Biochemistry : IJCB·Donatien GatsingGodwin I Adoga
Nov 16, 1987·Clinica Chimica Acta; International Journal of Clinical Chemistry·H MatsukuraN Sakuragawa
Jan 1, 1988·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·M Gumbleton, P J Nicholls
Jun 15, 2005·Journal of Pharmacological and Toxicological Methods·Susan G Emeigh Hart
Oct 1, 1981·Journal of Clinical Pathology·D F Davidson
Aug 1, 1983·Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Für Klinische Chemie Und Klinische Biochemie·W PapeK Baumann
Apr 1, 1985·Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Für Klinische Chemie Und Klinische Biochemie·F BarragánA Castelao
Aug 1, 1988·Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Für Klinische Chemie Und Klinische Biochemie·U BurchardtA Barth
Dec 1, 1991·European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies·D BalschunW Stein
Oct 4, 2006·Expert Opinion on Drug Metabolism & Toxicology·Vishal S Vaidya, Joseph V Bonventre
Jan 1, 1985·Uremia Investigation·D T PlummerJ D Haslam
Jul 1, 1987·Journal of Clinical Pharmacology·M TuoniH L Meltzer
Jan 1, 1997·International Urology and Nephrology·A NeimarkI Celovalnikova
Feb 1, 1982·British Journal of Clinical Pharmacology·J A ThomisL Dettli
Jul 23, 1999·Renal Failure·R P WedeenM Gochfeld

Citations

Feb 1, 1973·The Journal of Pediatrics·I S Salafsky, H L Nadler
Mar 25, 1969·Journal of Chromatography·M WernerM Atoba
Oct 4, 1963·Deutsche medizinische Wochenschrift·J ASCHOFF

Related Concepts

GLB1
Exo-beta-D-Glucuronidase
GUSB
Cerebroside-Sulfatase
Glucosidase
Krebiozen
Galactosidase
Circadian Rhythms
Sulfatases

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.